Morphic News

Morphic Holding Launches New Stock Offering, Ends Previous Deal

TipRanks17:43 ET

Express News | Morphic - May Offer and Sell, From Time to Time at Its Sole Discretion, Shares of Its Common Stock, Having Price of up to $350 Mln

Reuters17:40 ET

Express News | Morphic Holding Inc - Entered Into a Sales Agreement With TD Securities (USA) LLC

Reuters17:38 ET

Morphic Holding Files Automatic Mixed Shelf

Seeking Alpha17:34 ET

Express News | Morphic Holding Files for Mixed Shelf Offering; Size Not Disclosed - SEC Filing

Reuters17:29 ET

Stifel Nicolaus Remains a Hold on Morphic Holding (MORF)

TipRanksApr 26 07:52 ET

Morphic Holding (MORF) Gets a Buy From RBC Capital

TipRanksApr 26 06:36 ET

Morphic Holding's Buy Rating Affirmed: Promising Trials and Strong Financial Outlook

TipRanksApr 26 05:22 ET

Morphic Holding Inc (MORF) Q1 2024 Earnings: A Detailed Review

Yahoo FinanceApr 25 08:37 ET

Express News | Morphic Therapeutic Ended First Quarter With $658.8M In Cash, Cash Equivalents, And Marketable Securities; Cash Runway Into Second Half Of 2027

BenzingaApr 25 07:31 ET

Express News | Morphic Holding Q1 2024 GAAP EPS $(0.91) Beats $(0.94) Estimate

BenzingaApr 25 07:31 ET

Morphic Holding 1Q Loss/Shr 91c >MORF

Morphic Holding 1Q Loss/Shr 91c >MORF

Dow JonesApr 25 07:01 ET

Press Release: Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024

Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024 - Enrollment continued on target in EMERALD-2 Phase 2b trial of MORF-057 in ulcerative colitis- -Appointed Dr.

Dow JonesApr 25 07:01 ET

Express News | Morphic Q1 Operating Income USD -53.604 Million

ReutersApr 25 07:00 ET

Express News | Morphic Q1 Net Income USD -45.294 Million

ReutersApr 25 07:00 ET

Express News | Morphic Q1 Basic EPS USD -0.91

ReutersApr 25 07:00 ET

Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024

- Enrollment continued on target in EMERALD-2 Phase 2b trial of MORF-057 in ulcerative colitis--Appointed Dr. Simon Cooper as Chief Medical Officer--Anticipate dosing first patient in GARNET Phase 2 s

MorphicApr 25 00:00 ET

What Makes Morphic (MORF) a New Buy Stock

Yahoo FinanceApr 24 12:00 ET

Bullish Morphic Holding Insiders Loaded Up On US$47.3m Of Stock

Multiple insiders secured a larger position in Morphic Holding, Inc. (NASDAQ:MORF) shares over the last 12 months. This is reassuring as this suggests that insiders have increased optimism about the c

Simply Wall StApr 19 07:11 ET

Morphic Fund: Ethical Investing Amid Global Growth

TipRanksApr 11 03:57 ET